JP2022505637A5 - - Google Patents
Info
- Publication number
- JP2022505637A5 JP2022505637A5 JP2021522048A JP2021522048A JP2022505637A5 JP 2022505637 A5 JP2022505637 A5 JP 2022505637A5 JP 2021522048 A JP2021522048 A JP 2021522048A JP 2021522048 A JP2021522048 A JP 2021522048A JP 2022505637 A5 JP2022505637 A5 JP 2022505637A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- salt according
- inhibitors
- hiv
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862749801P | 2018-10-24 | 2018-10-24 | |
| US62/749,801 | 2018-10-24 | ||
| PCT/IB2019/059018 WO2020084491A1 (en) | 2018-10-24 | 2019-10-22 | Inhibitors of human immunodeficiency virus replication |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022505637A JP2022505637A (ja) | 2022-01-14 |
| JP2022505637A5 true JP2022505637A5 (cg-RX-API-DMAC7.html) | 2022-11-01 |
| JP7532354B2 JP7532354B2 (ja) | 2024-08-13 |
Family
ID=68344932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522048A Active JP7532354B2 (ja) | 2018-10-24 | 2019-10-22 | ヒト免疫不全ウイルス複製の阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210395262A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3870576B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7532354B2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2971987T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020084491A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA53973A (fr) | 2018-10-24 | 2022-02-09 | Viiv Healthcare Uk No 5 Ltd | Inhibiteurs de la réplication du virus de l'immunodéficience humaine |
| ES2969030T3 (es) * | 2018-10-29 | 2024-05-16 | Viiv Healthcare Uk No 5 Ltd | Derivados de quinazolinil-indazol y su uso como inhibidores de replicación de virus de inmunodeficiencia humana |
| US20210395248A1 (en) * | 2018-11-05 | 2021-12-23 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| TW202128648A (zh) * | 2019-10-04 | 2021-08-01 | 英商Viiv醫療保健英國(No 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| WO2021070054A1 (en) * | 2019-10-08 | 2021-04-15 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| US12564595B2 (en) | 2019-11-28 | 2026-03-03 | Shionogi & Co., Ltd. | Prophylactic and therapeutic pharmaceutical agent for HIV infectious diseases characterized by comprising combination of integrase inhibitor and anti-HIV agent |
| TW202448483A (zh) | 2023-05-31 | 2024-12-16 | 美商基利科學股份有限公司 | 用於hiv之治療性化合物 |
| AR132951A1 (es) | 2023-06-15 | 2025-08-13 | Viiv Healthcare Uk No 5 Ltd | Métodos e intermedios para preparar compuestos |
| WO2025169059A1 (en) | 2024-02-05 | 2025-08-14 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102464654B (zh) | 2010-11-12 | 2016-01-13 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| CA2840095A1 (en) | 2011-07-06 | 2013-01-10 | Gilead Sciences, Inc. | Compounds for the treatment of hiv |
| CN102863512B (zh) | 2011-07-07 | 2016-04-20 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| US9220710B2 (en) | 2013-01-09 | 2015-12-29 | Gilead Sciences, Inc. | Therapeutic compounds |
| EP2943493B1 (en) | 2013-01-09 | 2017-08-02 | Gilead Sciences, Inc. | Therapeutic compounds for the treatment of viral infections |
| TW201443037A (zh) | 2013-01-09 | 2014-11-16 | Gilead Sciences Inc | 治療用化合物 |
| TWI694071B (zh) | 2013-03-01 | 2020-05-21 | 美商基利科學股份有限公司 | 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物 |
| WO2015130964A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Therapeutic compounds |
| WO2015130966A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Antiviral agents |
| US9873680B2 (en) | 2014-08-29 | 2018-01-23 | Gilead Sciences, Inc. | Therapeutic compounds |
| LT3347352T (lt) * | 2016-08-19 | 2019-08-12 | Gilead Sciences, Inc. | Terapiniai junginiai, naudotini živ viruso infekcijos profilaktikai arba terapiniam gydymui |
| TW201906834A (zh) * | 2017-05-02 | 2019-02-16 | 英商Viiv醫療保健英國(No.5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| WO2019161017A1 (en) | 2018-02-15 | 2019-08-22 | Gilead Sciences, Inc. | Pyridine derivatives and their use for treating hiv infection |
| KR102847339B1 (ko) | 2018-02-16 | 2025-08-19 | 길리애드 사이언시즈, 인코포레이티드 | 레트로비리다에 바이러스 감염의 치료에 유용한 치료 화합물을 제조하기 위한 방법 및 중간체 |
| JP7361766B2 (ja) * | 2018-09-14 | 2023-10-16 | ヴィーブ ヘルスケア ユーケー(ナンバー5)リミテッド | ヒト免疫不全ウイルス複製の阻害剤 |
| WO2020058844A1 (en) * | 2018-09-20 | 2020-03-26 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| PT3870575T (pt) * | 2018-10-25 | 2023-05-12 | Viiv Healthcare Uk No 5 Ltd | Inibidores da replicação do vírus da imunodeficiência humana |
| US20210395248A1 (en) * | 2018-11-05 | 2021-12-23 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| JP2022506399A (ja) * | 2018-11-05 | 2022-01-17 | ヴィーブ ヘルスケア ユーケー(ナンバー5)リミテッド | ヒト免疫不全ウイルス複製の阻害剤 |
-
2019
- 2019-10-22 WO PCT/IB2019/059018 patent/WO2020084491A1/en not_active Ceased
- 2019-10-22 JP JP2021522048A patent/JP7532354B2/ja active Active
- 2019-10-22 EP EP19794682.5A patent/EP3870576B1/en active Active
- 2019-10-22 US US17/284,816 patent/US20210395262A1/en not_active Abandoned
- 2019-10-22 ES ES19794682T patent/ES2971987T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022505597A5 (cg-RX-API-DMAC7.html) | ||
| JP2022505841A5 (cg-RX-API-DMAC7.html) | ||
| JP2022505989A5 (cg-RX-API-DMAC7.html) | ||
| JP2022500425A5 (cg-RX-API-DMAC7.html) | ||
| JP2022501370A5 (cg-RX-API-DMAC7.html) | ||
| ES2670769T3 (es) | Derivados de (hetero)arilacetamida como agentes antirretrovirales | |
| CA3089590A1 (en) | Pyridine derivatives and their use for treating hiv infection | |
| JPWO2023054292A5 (cg-RX-API-DMAC7.html) | ||
| JP2006506425A5 (cg-RX-API-DMAC7.html) | ||
| JP2022081661A5 (cg-RX-API-DMAC7.html) | ||
| RU2001132635A (ru) | Производные пиперидина, применимые в качестве антагонистов сс R5 | |
| JP2020507589A5 (cg-RX-API-DMAC7.html) | ||
| JP2008508214A (ja) | 女性の性障害の治療用ピペラジン誘導体 | |
| JP2025508656A5 (cg-RX-API-DMAC7.html) | ||
| CA2541781A1 (en) | 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of respiratory illnesses | |
| JP2023544716A5 (cg-RX-API-DMAC7.html) | ||
| JP2023512664A5 (cg-RX-API-DMAC7.html) | ||
| RU2008142598A (ru) | Селективные гидроксаматные ингибиторы ммп | |
| CN110612286A (zh) | 氰基取代的稠合双环衍生物及其制备方法和用途 | |
| RU2007105582A (ru) | Агонисты рецепторов никотина и способы их применения для лечения воспалительных заболеваний | |
| ES2733756T3 (es) | Agentes terapéuticos para el tratamiento de hipertensión ocular | |
| CN100475209C (zh) | 抗冠状病毒剂 | |
| JP7136910B2 (ja) | 乾性眼の予防または治療のための組成物 | |
| JP2025507308A5 (cg-RX-API-DMAC7.html) | ||
| EP1521581B1 (en) | Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocarditis |